These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 11192587)

  • 21. The catecholamine release-inhibitory peptide catestatin (chromogranin A344-363) modulates myocardial function in fish.
    Imbrogno S; Garofalo F; Cerra MC; Mahata SK; Tota B
    J Exp Biol; 2010 Nov; 213(Pt 21):3636-43. PubMed ID: 20952611
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Catecholamine release-inhibitory peptide catestatin (chromogranin A(352-372)): naturally occurring amino acid variant Gly364Ser causes profound changes in human autonomic activity and alters risk for hypertension.
    Rao F; Wen G; Gayen JR; Das M; Vaingankar SM; Rana BK; Mahata M; Kennedy BP; Salem RM; Stridsberg M; Abel K; Smith DW; Eskin E; Schork NJ; Hamilton BA; Ziegler MG; Mahata SK; O'Connor DT
    Circulation; 2007 May; 115(17):2271-81. PubMed ID: 17438154
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Catestatin (chromogranin A344-358) stimulates release of histamine from rat pleural and peritoneal mast cells.
    Krüuger PG; Mahata SK; Helle KB
    Ann N Y Acad Sci; 2002 Oct; 971():349-51. PubMed ID: 12438149
    [No Abstract]   [Full Text] [Related]  

  • 24. Mechanism of cardiovascular actions of the chromogranin A fragment catestatin in vivo.
    Kennedy BP; Mahata SK; O'Connor DT; Ziegler MG
    Peptides; 1998; 19(7):1241-8. PubMed ID: 9786174
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chromogranins: current concepts. Structural and functional aspects.
    Aunis D; Metz-Boutigue MH
    Adv Exp Med Biol; 2000; 482():21-38. PubMed ID: 11192582
    [No Abstract]   [Full Text] [Related]  

  • 26. Catestatin is a novel endogenous peptide that regulates cardiac function and blood pressure.
    Mahapatra NR
    Cardiovasc Res; 2008 Dec; 80(3):330-8. PubMed ID: 18541522
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early decline in the catecholamine release-inhibitory peptide catestatin in humans at genetic risk of hypertension.
    O'Connor DT; Kailasam MT; Kennedy BP; Ziegler MG; Yanaihara N; Parmer RJ
    J Hypertens; 2002 Jul; 20(7):1335-45. PubMed ID: 12131530
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Peptidergic activation of transcription and secretion in chromaffin cells. Cis and trans signaling determinants of pituitary adenylyl cyclase-activating polypeptide (PACAP).
    Taupenot L; Mahata SK; Wu H; O'Connor DT
    J Clin Invest; 1998 Feb; 101(4):863-76. PubMed ID: 9466982
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Natural variation within the neuronal nicotinic acetylcholine receptor cluster on human chromosome 15q24: influence on heritable autonomic traits in twin pairs.
    Rana BK; Wessel J; Mahboubi V; Rao F; Haeller J; Gayen JR; Eskin E; Valle AM; Das M; Mahata SK; Taupenot L; Stridsberg M; Talley TT; Ziegler MG; Smith DW; Schork NJ; O'Connor DT; Taylor P
    J Pharmacol Exp Ther; 2009 Nov; 331(2):419-28. PubMed ID: 19671882
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Signal-mediated sorting of chromogranins to secretory granules.
    Gerdes HH; Glombik MM
    Adv Exp Med Biol; 2000; 482():41-54. PubMed ID: 11192600
    [No Abstract]   [Full Text] [Related]  

  • 31. The catecholamine release-inhibitory "catestatin" region of chromogranin a: early decline in humans at genetic risk of hypertension.
    O'Connor DT; Kailasam MT; Kennedy BP; Ziegler MG; Yanaihara N; Parmer RJ
    Ann N Y Acad Sci; 2002 Oct; 971():533-5. PubMed ID: 12438176
    [No Abstract]   [Full Text] [Related]  

  • 32. Proteolytic cleavage of chromogranin A (CgA) by plasmin. Selective liberation of a specific bioactive CgA fragment that regulates catecholamine release.
    Jiang Q; Taupenot L; Mahata SK; Mahata M; O'Connor DT; Miles LA; Parmer RJ
    J Biol Chem; 2001 Jul; 276(27):25022-9. PubMed ID: 11342539
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of chromogranin A transcription and catecholamine secretion by the neuropeptide PACAP. Stimulation and desensitization.
    Taupenot L; Mahata M; Mahata SK; Wu H; O'Connor DT
    Adv Exp Med Biol; 2000; 482():97-111. PubMed ID: 11192604
    [No Abstract]   [Full Text] [Related]  

  • 34. Inhibition of parathyroid hormone secretion by amino-terminal chromogranin peptides.
    Russell J; Gee P; Liu SM; Angeletti RH
    Endocrinology; 1994 Jul; 135(1):337-42. PubMed ID: 8013369
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stimulus coupling to transcription versus secretion in pheochromocytoma cells. Convergent and divergent signal transduction pathways and the crucial roles for route of cytosolic calcium entry and protein kinase C.
    Tang K; Wu H; Mahata SK; Mahata M; Gill BM; Parmer RJ; O'Connor DT
    J Clin Invest; 1997 Sep; 100(5):1180-92. PubMed ID: 9276735
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Catestatin: a multifunctional peptide from chromogranin A.
    Mahata SK; Mahata M; Fung MM; O'Connor DT
    Regul Pept; 2010 Jun; 162(1-3):33-43. PubMed ID: 20116404
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chromogranin A and its derived peptides in the rat and porcine gastro-entero-pancreatic system. Expression, localization, and characterization.
    Curry WJ; Norlén P; Barkatullah SC; Johnston CF; Håkanson R; Hutton JC
    Adv Exp Med Biol; 2000; 482():205-13. PubMed ID: 11192581
    [No Abstract]   [Full Text] [Related]  

  • 38. Both rare and common polymorphisms contribute functional variation at CHGA, a regulator of catecholamine physiology.
    Wen G; Mahata SK; Cadman P; Mahata M; Ghosh S; Mahapatra NR; Rao F; Stridsberg M; Smith DW; Mahboubi P; Schork NJ; O'Connor DT; Hamilton BA
    Am J Hum Genet; 2004 Feb; 74(2):197-207. PubMed ID: 14740315
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A molecular dynamics study of catestatin docked on nicotinic acetylcholine receptors to identify amino acids potentially involved in the binding of chromogranin A fragments.
    Kraszewski S; Drabik D; Langner M; Ramseyer C; Kembubpha S; Yasothornsrikul S
    Phys Chem Chem Phys; 2015 Jul; 17(26):17454-60. PubMed ID: 26079001
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chromogranin A: posttranslational modifications in secretory granules.
    Barbosa JA; Gill BM; Takiyyuddin MA; O'Connor DT
    Endocrinology; 1991 Jan; 128(1):174-90. PubMed ID: 1986917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.